# FDA Inspection 1018900 - Legacy Pharmaceuticals Switzerland GmbH - July 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/legacy-pharmaceuticals-switzerland-gmbh/d687ff6c-8625-4830-98d4-e5a2f1f54816
Source feed: FDA_Inspections

> FDA Inspection 1018900 for Legacy Pharmaceuticals Switzerland GmbH on July 21, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018900
- Company Name: Legacy Pharmaceuticals Switzerland GmbH
- Inspection Date: 2017-07-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 661172 - 2010-03-30](https://www.keypedia.com/records/fda_inspections/legacy-pharmaceuticals-switzerland-gmbh/1b1f31a0-0d08-48c9-85e1-cad3160fdf78)

Company: https://www.keypedia.com/companies/legacy-pharmaceuticals-switzerland-gmbh/12fbec96-87c8-4cc5-9c5d-f13acd0766f8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c